Report cover image

Hematology Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Aug 26, 2024
Length 77 Pages
SKU # GBDT19176704

Description

Hematology Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Hematology Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Hematology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hematology tests include various blood tests that help diagnose and monitor various conditions.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Hematology Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hematology Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hematology Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

77 Pages
    • Hematology Tests Overview
    • Hematology Tests - Pipeline Products by Stage of Development
    • Hematology Tests - Pipeline Products by Segment
    • Hematology Tests - Pipeline Products by Territory
    • Hematology Tests - Pipeline Products by Regulatory Path
    • Hematology Tests - Pipeline Products by Estimated Approval Date
    • Hematology Tests Companies - Pipeline Products by Stage of Development
    • Hematology Tests - Pipeline Products by Stage of Development
    • Abionic SA Company Overview
    • Aptitude Medical Systems Inc Company Overview
    • Bio Vitos Pharma AB Company Overview
    • Biochip Labs Inc Company Overview
    • BioMedomics Inc Company Overview
    • Biosurfit, SA Company Overview
    • DxDiscovery Inc Company Overview
    • Epimune GmbH Company Overview
    • Flobio LLC Company Overview
    • genedrive plc Company Overview
    • Group K Diagnostics Company Overview
    • Hemex Health Inc Company Overview
    • McMaster University Company Overview
    • MiCo BioMed Co Ltd Company Overview
    • Ohio State University Company Overview
    • Optolane Technologies Inc Company Overview
    • PortaScience Inc Company Overview
    • QSTAG Co Ltd Company Overview
    • Retham Technologies LLC Company Overview
    • rHealth Company Overview
    • Sanguina LLC Company Overview
    • ShanMukha Innovations Pvt Ltd Company Overview
    • Siemens Healthcare Diagnostics Inc Company Overview
    • Silver Lake Research Corporation Company Overview
    • T2 Biosystems Inc Company Overview
    • University of Melbourne Company Overview
    • VitaMe Technologies Inc Company Overview
    • Jul 22, 2024: Relentless Health to Partner with Firefighters to Deliver PFAS Testing
    • Jun 19, 2024: Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024
    • May 08, 2024: Biohit Notice of Annual General Meeting
    • May 07, 2024: Siemens Healthineers on Track to Meet Fiscal Year 2024 Targets After Second Quarter
    • May 07, 2024: Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference
    • Apr 03, 2024: PatientPoint Appoints Sean Slovenski as President to Drive Innovation and Growth
    • Mar 19, 2024: Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
    • Mar 18, 2024: Siemens Healthineers Intends to Close Fast Track Diagnostics
    • Feb 05, 2024: Study of First Affordable and Rapid Test for Beta Thalassemia Performs at 99% Accuracy in Diagnosing the Blood Disorder
    • Jan 17, 2024: Capitainer Opens New qDBS Microsampling Laboratory in Rhode Island, U.S.
    • Jan 02, 2024: Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 42nd Annual Healthcare Conference
    • Nov 13, 2023: ARUP receives CE mark for AAV5 DetectCDx test
    • Oct 25, 2023: Sanguina Receives CLIA Approval For AnemoCheck Home
    • Oct 19, 2023: Sanguina Obtains Additional 510(k) Clearance for AnemoCheck
    • Oct 18, 2023: FloBio gets FDA breakthrough device status for bleeding risk diagnostic test
    • Oct 05, 2023: Sanguina receives US FDA clearance for haemoglobin test kit
    • Sep 29, 2023: ARUP's New Institute for Research and Innovation in Diagnostic and Precision Medicine Will Forge the Future of Laboratory Medicine
    • Sep 11, 2023: Capitainer-backed initiative in personalized medicine and diagnostics secures a SEK 12 million boost from KK-stiftelsen
    • Sep 08, 2023: Quest Diagnostics to Speak at the Baird 2023 Global Healthcare Conference
    • Aug 28, 2023: Bio-Rad to Participate in Fireside Chat During Wells Fargo's 2023 Healthcare Conference
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us